Pediatric Emergency Department Utilization and Reliance by Insurance Coverage in the United States

Lauren E Schlichting1, Michelle L Rogers1, Annie Gjelsvik1,2,3

  • 1Hassenfeld Child Health Innovation Institute, Providence, RI.

Insights

Children with public insurance are more likely to use emergency departments (EDs) frequently and rely on them for healthcare. Insurance status and demographics significantly predict ED utilization and reliance in children.

Area of Science:

  • Pediatric Health Services Research
  • Health Economics
  • Public Health Policy

Background:

  • The emergency department (ED) is a primary healthcare source for many children, for both urgent and non-urgent needs.
  • Understanding patterns of ED utilization, repeat visits, and ED reliance (EDR) is crucial for identifying children dependent on this resource.

Purpose of the Study:

  • To examine emergency department (ED) utilization among children aged 0-17 years.
  • To analyze the association between health insurance coverage and overall ED utilization, repeat ED visits, and ED reliance (EDR).

Main Methods:

  • Utilized nationally representative data from the 2010-2014 Medical Expenditure Panel Survey.
  • Employed multivariate models to analyze annual ED utilization, repeat utilization, and EDR by insurance coverage, controlling for complex survey design and weighting.
  • Defined high EDR as over 33% of annual outpatient visits occurring in the ED.

Main Results:

  • Approximately 12% of children visited an ED annually; those with public insurance had higher utilization rates compared to privately insured or uninsured children.
  • Children with public insurance were more likely to have repeat ED visits and higher ED reliance (EDR). Uninsured children also showed higher EDR.
  • Younger children (age 3 and under) and specific racial/ethnic groups were more likely to utilize the ED, highlighting demographic influences.

Conclusions:

  • Health insurance coverage is a significant factor associated with overall ED utilization, repeat visits, and reliance.
  • Demographic characteristics such as sex, age, income, and race/ethnicity are important predictors of ED utilization and reliance among children.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
373
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22